Central actions of somatostatin-28 and oligosomatostatin agonists to prevent components of the endocrine, autonomic and visceral responses to stress through interaction with different somatostatin receptor subtypes

Current Pharmaceutical Design

Volumn 19, Issue 1, 2013, Pages 98-105

  Stengel, Andreas ^a,b   Rivier, Jean ^c   Taché, Yvette ^a  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Autonomic nervous system; Fecal pellet output; Food intake; Gastrointestinal motility; Octreotide; ODT8 SST; Thermogenesis

Indexed keywords

5 HYDROXYTRYPTOPHAN; ADRENALIN; ATROPINE; CH 275; CORTICOTROPIN; DC 32 87; DEXAMETHASONE; DEXTRO PHENYLALANYLPHENYLALANYLPHENYLALANYL DEXTRO TRYPTOPHYLLYSYLTHREONYLPHENYLALANYLTHREONINAMIDE; DEXTRO PHENYLALANYLPHENYLALANYLTYROSYL DEXTRO TRYPTOPHYLLYSYLVALYLPHENYLALANYL DEXTRO [3 (2 NAPHTHYL)ALANINAMIDE]; DIZOCILPINE; GHRELIN; HISTAMINE; INDOMETACIN; INTERLEUKIN 1; L 779 976; L 803 087; N (2 AMINOETHYL) N [4 (BENZYLOXY) 3 METHOXYBENZYL]THIOPHENE 2 CARBOXAMIDE HYDROCHLORIDE; NALOXONE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; OCTREOTIDE; OLIGOSOMATOSTATIN AGONIST; PROTEIN FOS; SOMATOSTATIN; SOMATOSTATIN 14; SOMATOSTATIN 28; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL AFFECTING AGENT; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AUTONOMIC NERVOUS SYSTEM; COLON MOTILITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; ENDOCRINE SYSTEM; FEEDING BEHAVIOR; GROWTH HORMONE RELEASE; NONHUMAN; PARASYMPATHETIC FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; STOMACH EMPTYING; STRESS; SYMPATHETIC FUNCTION; THERMOGENESIS;

EID: 84873958606     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128130114     Document Type: Review

References (101)

1. Brazeau P, Vale W, Burgus R, et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973; 179: 77-9.
2. Pradayrol L, Jornvall H, Mutt V, Ribet A. N-terminally extended somatostatin: the primary structure of somatostatin-28. FEBS Lett 1980; 109: 55-8.
3. Olias G, Viollet C, Kusserow H, Epelbaum J, Meyerhof W. Regulation and function of somatostatin receptors. J Neurochem 2004; 89: 1057-91.
4. Brown M, Taché Y. Hypothalamic peptides: central nervous system control of visceral functions. Fed Proc 1981; 40: 2565-9.
5. Finley JC, Maderdrut JL, Roger LJ, Petrusz P. The immunocytochemical localization of somatostatin-containing neurons in the rat central nervous system. Neuroscience 1981; 6: 2173-92.
6. Johansson O, Hokfelt T, Elde RP. Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat. Neuroscience 1984; 13: 265-339.
7. Moga MM, Gray TS. Evidence for corticotropin-releasing factor, neurotensin, and somatostatin in the neural pathway from the central nucleus of the amygdala to the parabrachial nucleus. J Comp Neurol 1985; 241: 275-84.
8. Fehlmann D, Langenegger D, Schuepbach E, Siehler S, Feuerbach D, Hoyer D. Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery. J Physiol Paris 2000; 94: 265-81.
9. Spary EJ, Maqbool A, Batten TF. Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation. J Chem Neuroanat 2008; 35: 49-66.
10. Dragunow M, Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 1989; 29: 261-5.
11. Sagar SM, Sharp FR, Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 1988; 240: 1328-31.
12. Senba E, Ueyama T. Stress-induced expression of immediate early genes in the brain and peripheral organs of the rat. Neurosci Res 1997; 29: 183-207.
13. Meddle SL, Bull PM, Leng G, Russell JA, Ludwig M. Somatostatin actions on rat supraoptic nucleus oxytocin and vasopressin neurones. J Neuroendocrinol 2010; 22: 438-45.
14. Kamegai J, Minami S, Sugihara H, Wakabayashi I. Barrel rotation evoked by intracerebroventricular injection of somatostatin and arginine-vasopressin is accompanied by the induction of c-fos gene expression in the granular cells of rat cerebellum. Brain Res Mol Brain Res 1993; 18: 115-20.
15. Grace CR, Erchegyi J, Koerber SC, Reubi JC, Rivier J, Riek R. Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR. J Med Chem 2006; 49: 4487-96.
16. Goebel M, Stengel A, Wang L, et al. Pattern of Fos expression in the brain induced by selective activation of somatostatin receptor 2 in rats. Brain Res 2010; 1351: 150-64.
17. Erchegyi J, Grace CR, Samant M, et al. Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity. J Med Chem 2008; 51: 2668-75.
18. Mori K, Kim J, Sasaki K. Electrophysiological effect of ghrelin and somatostatin on rat hypothalamic arcuate neurons in vitro. Peptides 2010; 31: 1139-45.
19. Chessell IP, Black MD, Feniuk W, Humphrey PP. Operational characteristics of somatostatin receptors mediating inhibitory actions on rat locus coeruleus neurones. Br J Pharmacol 1996; 117: 1673-78.
20. Connor M, Bagley EE, Mitchell VA, Ingram SL, Christie MJ, Humphrey PP, Vaughan CW. Cellular actions of somatostatin on rat periaqueductal grey neurons in vitro. Br J Pharmacol 2004; 142: 1273-80.
21. Bereiter DA. Morphine and somatostatin analogue reduce c-fos expression in trigeminal subnucleus caudalis produced by corneal stimulation in the rat. Neuroscience 1997; 77: 863-74.
22. Arancibia S, Rage F, Grauges P, Gomez F, Tapia-Arancibia L, Armario A. Rapid modifications of somatostatin neuron activity in the periventricular nucleus after acute stress. Exp Brain Res 2000; 134: 261-7.
23. Negro-Vilar A, Saavedra JM. Changes in brain somatostatin and vasopressin levels after stress in spontaneously hypertensive and Wistar-Kyoto rats. Brain Res Bull 1980; 5: 353-8.
24. Nakamura H, Moroji T, Nagase H, Okazawa T, Okada A. Changes of cerebral vasoactive intestinal polypeptide-and somatostatin-like immunoreactivity induced by noise and whole-body vibration in the rat. Eur J Appl Physiol Occup Physiol 1994; 68: 62-7.
25. Arancibia S, Epelbaum J, Boyer R, Assenmacher I. In vivo release of somatostatin from rat median eminence after local K+ infusion or delivery of nociceptive stress. Neurosci Lett 1984; 50: 97-102.
26. Benyassi A, Gavalda A, Armario A, Arancibia S. Role of somatostatin in the acute immobilization stress-induced GH decrease in rat. Life Sci 1993; 52: 361-70.
27. Zhang K, Hamanaka K, Kitayama I, et al. Decreased expression of the mRNA for somatostatin in the periventricular nucleus of depression-model rats. Life Sci 1999; 65: PL87-94.
28. Deutch AY, Bean AJ, Bissette G, Nemeroff CB, Robbins RJ, Roth RH. Stress-induced alterations in neurotensin, somatostatin and corticotropin-releasing factor in mesotelencephalic dopamine system regions. Brain Res 1987; 417: 350-4.
29. Estupina C, Abarca J, Arancibia S, Belmar J. N-methyl-D-aspartate receptor involvement in dexamethasone and stress-induced hypothalamic somatostatin release in rats. Neurosci Lett 1996; 219: 203-6.
30. Arancibia S, Payet O, Givalois L, Tapia-Arancibia L. Acute stress and dexamethasone rapidly increase hippocampal somatostatin synthesis and release from the dentate gyrus hilus. Hippocampus 2001; 11: 469-77.
31. Franco-Bourland RE. Vasopressinergic, oxytocinergic, and somatostatinergic neuronal activity after adrenalectomy and immobilization stress. Neurochem Res 1998; 23: 695-701.
32. Chen XQ, Du JZ. Hypoxia influences somatostatin release in rats. Neurosci Lett 2000; 284: 151-4.
33. Arancibia S, Estupina C, Tapia-Arancibia L. Rapid reduction in somatostatin mRNA expression by hypothalamic neurons induced by dexamethasone. Neuroreport 2000; 11: 3163-7.
34. Nanda SA, Qi C, Roseboom PH, Kalin NH. Predator stress induces behavioral inhibition and amygdala somatostatin receptor 2 gene expression. Genes Brain Behav 2008; 7: 639-48.
35. Brown MR, Rivier C, Vale W. Central nervous system regulation of adrenocorticotropin secretion: role of somatostatins. Endocrinology 1984; 114: 1546-9.
36. Wang XM, Tresham JJ, Coghlan JP, Scoggins BA. Intracerebroventricular infusion of a cyclic hexapeptide analogue of somatostatin inhibits hemorrhage-induced ACTH release. Neuroendocrinology 1987; 45: 325-7.
37. Viollet C, Vaillend C, Videau C, et al. Involvement of sst2 somatostatin receptor in locomotor, exploratory activity and emotional reactivity in mice. Eur J Neurosci 2000; 12: 3761-70.
38. Katakami H, Arimura A, Frohman LA. Involvement of hypothalamic somatostatin in the suppression of growth hormone secretion by central corticotropin-releasing factor in conscious male rats. Neuroendocrinology 1985; 41: 390-3.
39. Rivier C, Vale W. Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat. Endocrinology 1985; 117: 2478-82.
40. Aguila MC, Pickle RL, Yu WH, McCann SM. Roles of somatostatin and growth hormone-releasing factor in ether stress inhibition of growth hormone release. Neuroendocrinology 1991; 54: 515-20.
41. Fisher DA, Brown MR. Somatostatin analog: plasma catecholamine suppression mediated by the central nervous system. Endocrinology 1980; 107: 714-8.
42. Feuerbach D, Fehlmann D, Nunn C, Siehler S, Langenegger D, Bouhelal R, Seuwen K, Hoyer D. Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor. Neuropharmacology 2000; 39: 1451-62.
43. Brown MR. Central nervous system sites of action of bombesin and somatostatin to influence plasma epinephrine levels. Brain Res 1983; 276: 253-7.
44. Carver-Moore K, Gray TS, Brown MR. Central nervous system site of action of bombesin to elevate plasma concentrations of catecholamines. Brain Res 1991; 541: 225-31.
45. Miles PD, Yamatani K, Brown MR, Lickley HL, Vranic M. Intracerebroventricular administration of somatostatin octapeptide counteracts the hormonal and metabolic responses to stress in normal and diabetic dogs. Metabolism 1994; 43: 1134-43.
46. Brown M, Fisher L, Mason RT, Rivier J, Vale W. Neurobiological actions of cysteamine. Fed Proc 1985; 44: 2556-60.
47. Brown MR, Fisher LA. Central nervous system actions of somatostatin-related peptides. Adv Exp Med Biol 1985; 188: 217-28.
48. Brown MR, Fisher LA, Sawchenko PE, Swanson LW, Vale WW. Biological effects of cysteamine: relationship to somatostatin depletion. Regul Pept 1983; 5: 163-79.
49. Somiya H, Tonoue T. Neuropeptides as central integrators of autonomic nerve activity: effects of TRH, SRIF, VIP and bombesin on gastric and adrenal nerves. Regul Pept 1984; 9: 47-52.
50. Strack AM, Sawyer WB, Platt KB, Loewy AD. CNS cell groups regulating the sympathetic outflow to adrenal gland as revealed by transneuronal cell body labeling with pseudorabies virus. Brain Res 1989; 491: 274-96.
51. Debas HT, Carvajal SH. Vagal regulation of acid secretion and gastrin release. Yale J Biol Med 1994; 67: 145-51.
52. Taché Y, Rivier J, Vale W, Brown M. Is somatostatin or a somatostatin-like peptide involved in central nervous system control of gastric secretion? Regul Pept 1981; 1: 307-15.
53. Yoneda M, Raybould H, Taché Y. Central action of somatostatin analog, SMS 201-995, to stimulate gastric acid secretion in rats. Peptides 1991; 12: 401-6.
54. Yoneda M, Taché Y. SMS 201-995-induced stimulation of gastric acid secretion via the dorsal vagal complex and inhibition via the hypothalamus in anaesthetized rats. Br J Pharmacol 1995; 116: 2303-9.
55. Martinez V, Coy DH, Taché Y. Influence of intracisternal injection of somatostatin analog receptor subtypes 2, 3 and 5 on gastric acid secretion in conscious rats. Neurosci Lett 1995; 186: 79-82.
56. Martinez V, Coy DH, Lloyd KC, Taché Y. Intracerebroventricular injection of somatostatin sst5 receptor agonist inhibits gastric acid secretion in rats. Eur J Pharmacol 1996; 296: 153-60.
57. Martinez V, Rivier J, Coy D, Taché Y. Intracisternal injection of somatostatin receptor 5-preferring agonists induces a vagal cholinergic stimulation of gastric emptying in rats. J Pharmacol Exp Ther 2000; 293: 1099-105.
58. Thoss VS, Perez J, Duc D, Hoyer D. Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain. Neuropharmacology 1995; 34: 1673-88.
59. 2 receptor-mediated orexigenic effect: role of neuropeptide Y and opioid signaling pathways in rats. Endocrinology 2010; 151: 4224-35.
60. Stengel A, Goebel-Stengel M, Wang L, Larauche M, Rivier J, Taché Y. Central somatostatin receptor 1 activation reverses acute stress-related alterations of gastric and colonic motor function in mice. Neurogastroenterol Motil 2011; 23: e223-36.
61. 2 receptor increases food intake, grooming behavior and rectal temperature in rats. J Physiol Pharmacol 2010; 61: 399-407.
62. Stengel A, Goebel-Stengel M, Wang L, et al. Central administration of pan-somatostatin agonist ODT8-SST prevents abdominal surgery-induced inhibition of circulating ghrelin, food intake and gastric emptying in rats. Neurogastroenterol Motil 2011; 23: e294-308.
63. Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC, Patel YC. Subtypes of the somatostatin receptor assemble as functional homo-and heterodimers. J Biol Chem 2000; 275: 7862-9.
64. Mönnikes H, Raybould HE, Schmidt B, Taché Y. CRF in the paraventricular nucleus of the hypothalamus stimulates colonic motor activity in fasted rats. Peptides 1993; 14: 743-7.
65. Mönnikes H, Schmidt BG, Tebbe J, Bauer C, Taché Y. Microinfusion of corticotropin releasing factor into the locus coeruleus/subcoeruleus nuclei stimulates colonic motor function in rats. Brain Res 1994; 644: 101-8.
66. Tebbe JJ, Pasat IR, Mönnikes H, Ritter M, Kobelt P, Schafer MK. Excitatory stimulation of neurons in the arcuate nucleus initiates central CRF-dependent stimulation of colonic propulsion in rats. Brain Res 2005; 1036: 130-8.
67. Schulz S, Handel M, Schreff M, Schmidt H, Hollt V. Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies. J Physiol Paris 2000; 94: 259-64.
68. 2 receptors delays gastric transit in mice. J Physiol 2004; 556: 221-34.
69. Wang L, Martinez V, Kimura H, Taché Y. 5-Hydroxytryptophan activates colonic myenteric neurons and propulsive motor function through 5-HT4 receptors in conscious mice. Am J Physiol Gastrointest Liver Physiol 2007; 292: G419-28.
70. Rezek M, Havlicek V, Leybin L, et al. Neostriatal administration of somatostatin: differential effect of small and large doses on behavior and motor control. Can J Physiol Pharmacol 1977; 55: 234-42.
71. Ishikawa Y, Shimatsu A, Murakami Y, Imura H. Barrel rotation in rats induced by SMS 201-995: suppression by ceruletide. Pharmacol Biochem Behav 1990; 37: 523-6.
72. Allen JP, Hathway GJ, Clarke NJ, et al. Somatostatin receptor 2 knockout/lacZ knockin mice show impaired motor coordination and reveal sites of somatostatin action within the striatum. Eur J Neurosci 2003; 17: 1881-95.
73. Hamada T, Shibata S, Tsuneyoshi A, Tominaga K, Watanabe S. Effect of somatostatin on circadian rhythms of firing and 2-deoxyglucose uptake in rat suprachiasmatic slices. Am J Physiol 1993; 265: R1199-204.
74. Rezek M, Havlicek V, Hughes KR, Friesen H. Central site of action of somatostatin (SRIF): role of hippocampus. Neuropharmacology 1976; 15: 499-504.
75. Lin MT, Chen JJ, Ho LT. Hypothalamic involvement in the hyperglycemia and satiety actions of somatostatin in rats. Neuroendocrinology 1987; 45: 62-7.
76. Danguir J. Food intake in rats is increased by intracerebroventricular infusion of the somatostatin analogue SMS 201-995 and is decreased by somatostatin antiserum. Peptides 1988; 9: 211-3.
77. Feifel D, Vaccarino FJ. Central somatostatin: a re-examination of its effects on feeding. Brain Res 1990; 535: 189-94.
78. Feifel D, Vaccarino FJ, Rivier J, Vale WW. Evidence for a common neural mechanism mediating growth hormone-releasing factor-induced and somatostatin-induced feeding. Neuroendocrinology 1993; 57: 299-305.
79. Tachibana T, Cline MA, Sugahara K, Ueda H, Hiramatsu K. Central administration of somatostatin stimulates feeding behavior in chicks. Gen Comp Endocrinol 2009; 161: 354-59.
80. Vijayan E, McCann SM. Suppression of feeding and drinking activity in rats following intraventricular injection of thyrotropin releasing hormone (TRH). Endocrinology 1977; 100: 1727-30.
81. Aponte G, Leung P, Gross D, Yamada T. Effects of somatostatin on food intake in rats. Life Sci 1984; 35: 741-6.
82. Tannenbaum GS, Patel YC. On the fate of centrally administered somatostatin in the rat: massive hypersomatostatinemia resulting from leakage into the peripheral circulation has effects on growth hormone secretion and glucoregulation. Endocrinology 1986; 118: 2137-43.
83. de la Cour CD, Norlen P, Hakanson R. Secretion of ghrelin from rat stomach ghrelin cells in response to local microinfusion of candidate messenger compounds: a microdialysis study. Regul Pept 2007; 143: 118-26.
84. Silva AP, Bethmann K, Raulf F, Schmid HA. Regulation of ghrelin secretion by somatostatin analogs in rats. Eur J Endocrinol 2005; 152: 887-94.
85. Schick RR, Schusdziarra V, Nussbaumer C, Classen M. Neuropeptide Y and food intake in fasted rats: effect of naloxone and site of action. Brain Res 1991; 552: 232-9.
86. Duran-Prado M, Malagon MM, Gracia-Navarro F, Castano JP. Dimerization of G protein-coupled receptors: new avenues for somatostatin receptor signalling, control and functioning. Mol Cell Endocrinol 2008; 286: 63-8.
87. Brown MR. Bombesin and somatostatin related peptides: effects on oxygen consumption. Brain Res 1982; 242: 243-6.
88. Guesdon B, Paradis E, Samson P, Richard D. Effects of intracerebroventricular and intra-accumbens melanin-concentrating hormone agonism on food intake and energy expenditure. Am J Physiol Regul Integr Comp Physiol 2009; 296: R469-75.
89. Stepanyan Z, Kocharyan A, Behrens M, Koebnick C, Pyrski M, Meyerhof W. Somatostatin, a negative-regulator of central leptin action in the rat hypothalamus. J Neurochem 2007; 100: 468-78.
90. Moller LN, Stidsen CE, Hartmann B, Holst JJ. Somatostatin receptors. Biochim Biophys Acta 2003; 1616: 1-84.
91. Stepanyan Z, Kocharyan A, Pyrski M, et al. Leptin-target neurones of the rat hypothalamus express somatostatin receptors. J Neuroendocrinol 2003; 15: 822-30.
92. Csaba Z, Simon A, Helboe L, Epelbaum J, Dournaud P. Targeting sst2A receptor-expressing cells in the rat hypothalamus through in vivo agonist stimulation: neuroanatomical evidence for a major role of this subtype in mediating somatostatin functions. Endocrinology 2003; 144: 1564-73.
93. Gardi J, Obal F, Jr., Fang J, Zhang J, Krueger JM. Diurnal variations and sleep deprivation-induced changes in rat hypothalamic GHRH and somatostatin contents. Am J Physiol 1999; 277: R1339-44.
94. Stengel A, Goebel M, Wang L, et al. Activation of brain somatostatin(2) receptors stimulates feeding in mice: Analysis of food intake microstructure. Physiol Behav 2010; 101: 614-22.
95. Geary N. A new way of looking at eating. Am J Physiol Regul Integr Comp Physiol 2005; 288: R1444-6.
96. Shibasaki T, Yamauchi N, Kato Y, et al. Involvement of corticotropin-releasing factor in restraint stress-induced anorexia and reversion of the anorexia by somatostatin in the rat. Life Sci 1988; 43: 1103-10.
97. Brown M, Ling N, Rivier J. Somatostatin-28, somatostatin-14 and somatostatin analogs: effects on thermoregulation. Brain Res 1981; 214: 127-35.
98. Lawrence CB, Rothwell NJ. Anorexic but not pyrogenic actions of interleukin-1 are modulated by central melanocortin-3/4 receptors in the rat. J Neuroendocrinol 2001; 13: 490-5.
99. Almeida MC, Hew-Butler T, Soriano RN, et al. Pharmacological blockade of the cold receptor TRPM8 attenuates autonomic and behavioral cold defenses and decreases deep body temperature. J Neurosci 2012; 32: 2086-99.
100. Lin MT, Uang WN, Ho LT, Chuang J, Fan LJ. Somatostatin: a hypothalamic transmitter for thermoregulation in rats. Pflugers Arch 1989; 413: 528-32.
101. Ao Y, Go VL, Toy N, et al. Brainstem thyrotropin-releasing hormone regulates food intake through vagal-dependent cholinergic stimulation of ghrelin secretion. Endocrinology 2006; 147: 6004-10.